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Directed Evolution of O6-Alkylguanine-DNA
Alkyltransferase for Efficient Labeling of
Fusion Proteins with Small Molecules In Vivo
the label is transferred with the benzyl group to the
reactive cysteine, yielding a stable thioether. Labeling
in bacteria and yeast is specific, as the respective en-
dogenous AGTs do not accept BG as substrates,
whereas for the labeling in mammalian cells, AGT-defi-
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Important for the versatility of the approach is theCH-1015 Lausanne
Switzerland observation that the reaction of hAGT fusion proteins
with 1 (i.e., 2–5) does not depend on the nature of the
label, allowing the covalent attachment of a wide variety
of different reporter molecules [9]. However, the effi-Summary
ciency of the in vivo labeling is determined by the speed
of the reaction, and the rate constant for the reactionWe report here the generation of mutants of the human
of hAGT with BG derivatives such as 3a is only 400O6-alkylguanine-DNA alkyltransferase (hAGT) for the
s1M1, four orders of magnitude below the reaction ofefficient in vivo labeling of fusion proteins with syn-
hAGT with its natural substrate, O6-methylguanine-DNAthetic reporter molecules. Libraries of hAGT were dis-
[9, 10]. Here, we report the generation of hAGT mutantsplayed on phage, and mutants capable of efficiently
with significantly increased activities against substratesreacting with the inhibitor O6-benzylguanine were se-
of type 1 and the use of these mutants for the efficientlected based on their ability to irreversibly transfer
labeling of hAGT fusion proteins in vivo and in vitro. Thethe benzyl group to a reactive cysteine residue. Using
characterization of the selected mutants also adds tosynthetic O6-benzylguanine derivatives, the selected
our understanding of the interaction of hAGT with itsmutant proteins allow for a highly efficient covalent
inhibitor BG.labeling of hAGT fusion proteins in vivo and in vitro
with small molecules and therefore should become
important tools for studying protein function in living
Results and Discussioncells. In addition to various applications in proteomics,
the selected mutants also yield insight into the interac-
To increase the activity of hAGT against BG derivativestion of the DNA repair protein hAGT with its inhibitor
of type 1, we envisioned using directed evolution basedO6-benzylguanine.
on phage display [12]. Active hAGT displayed on phage
can be covalently labeled with digoxigenin or biotin us-
Introduction ing substrates such as 2 or 3 and subsequently enriched
out of libraries of phage displaying no or less active
The specific in vivo labeling of proteins with small re- hAGT using immobilized anti-digoxigenin antibody or
porter molecules has great potential for studying protein avidin. We have previously shown that hAGT can be
function. So far, in vivo protein labeling is achieved by displayed functionally on phage  [13]; however, in our
either introducing the label as an unnatural amino acid hands this system was not suitable for directed evolu-
using nonsense codon suppression technology [1], or tion of hAGT (A.K., K.J., unpublished data). We therefore
the protein of interest is expressed as a fusion protein decided to display hAGT libraries on filamentous phage
with a polypeptide or protein that mediates the labeling M13 as a fusion protein with g3p using phagemid
[2–9]. Examples of polypeptides or proteins that mediate pAK100 [14]. Although proteins displayed on filamen-
the in vivo labeling of fusion proteins are proteins that tous phage have to fold under the oxidizing conditions of
noncovalently bind a reporter molecule [2–5] or polypep- the periplasm, functional display of proteins with highly
tides containing cysteines that form stable complexes reactive cysteine residues on filamentous phage has
with biarsenical compounds [6–8]. We have recently in- already been demonstrated [15, 16]. To investigate if
troduced a method for the specific labeling of fusion hAGT is active as a g3p fusion protein on the surface
proteins in vivo [9] which is based on the reaction of of filamentous phage, model selections were performed;
the human DNA repair protein O6-alkylguanine-DNA al- mixtures of phage displaying hAGT and phage dis-
kyltransferase (hAGT, 207 residues) with O6-benzylgua- playing no hAGT were incubated with 2 and phage la-
nine (BG) derivatives of type 1 (Figure 1). The normal beled with digoxigenin subsequently captured using
function of hAGT is to repair O6-alkylated guanine in magnetic beads covered with anti-digoxigenin antibody.
DNA by transferring the alkyl group in an SN2 reaction In these experiments, phage displaying hAGT were en-
to a reactive cysteine residue (Cys145) [10]. The repair riched by a factor of about 400 per round, indicating
mechanism is unusual, as the protein is irreversibly inac- that hAGT can indeed be functionally displayed on fila-
tivated [10]. Consequently, the reaction of hAGT fusion mentous phage.
proteins with BG derivatives of type 1 leads to the irre- For the creation of a library of hAGT mutants, we made
versible and covalent labeling of the fusion proteins as use of structural and biochemical information available
on hAGT (Figure 2) [10, 17–20], identifying four amino
acids that could affect the reactivity of hAGT toward*Correspondence: kai.johnsson@epfl.ch
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Figure 1. Labeling of hAGT Fusion Proteins
(A) Labeling of hAGT fusion proteins with 1.
The protein of interest can be fused either to
the N or C terminus of hAGT.
(B) BG derivatives used throughout this work
for labeling with (i) digoxigenin (2), (ii) biotin
(3a, b) and (iii) fluorescein (4 and 5).
BG (Pro140, Asn157, Ser159, Gly160). The side chain of library of 2.6  105 independent hAGT mutants after
electroporation of the corresponding pAK100 vector intoPro140 is believed to undergo an important hydrophobic
interaction with the benzyl ring of BG [17–19], and the E. coli XL1-Blue. Sequencing of five randomly picked
clones confirmed the randomization at residues 140,mutation Gly160Trp has been shown to increase the
reactivity of hAGT toward BG, presumably through hy- 157, 159, and 160. To ensure enrichment of highly active
hAGT mutants in the selections, the phage library wasdrophobic interactions [17, 20]. The side chains of
incubated with low concentrations of 2 for short periodsAsn157 [17] and Ser159 [17, 18] have both been pro-
of time; in the first round, phage were incubated with 2posed to form a hydrogen bond with the N7 of BG, and
(1 M) for 10 min and quenched with BG (100 M),the C of Ser159 has been proposed to make contact
and labeled phage was captured with magnetic beadswith the benzyl ring of BG [19].
covered with anti-digoxigenin antibody, whereas in theThe codons for residues 140, 157, 159, and 160 were
second and third round, the incubation time was re-randomized using synthetic oligonucleotides, yielding a
duced to 5 min and 40 s, respectively. The rate for the
reaction of wild-type with BG derivatives of the type
1 is sufficiently slow so that the employed selection
conditions should indeed lead to an enrichment of mu-
tant proteins with activities higher than wild-type. After
the third round, nine clones were analyzed by DNA se-
quencing (Table 1). Seven of the nine selected clones
Table 1. Sequences of Selected hAGT Mutants at Randomized
Residues and Their Activities (kobs) as GST-hAGT Fusion
Proteins against 3a
Res. 140 Res. 157 Res. 159 Res. 160 kobs (s1M1)
Wild-type Pro Asn Ser Gly 400
PGSG Pro Gly Ser Gly 1200
PGEG Pro Gly Glu Gly 8000
PGEA Pro Gly Glu Ala 6000
PGNW Pro Gly Asn Trp 3200Figure 2. BG Docked into the Active Site of hAGT [16, 17]
PGQW Pro Gly Gln Trp 500
Highlighted are the reactive Cys145 and the randomized residues PPQC Pro Pro Gln Cys 800
Pro140, Asn157, Ser159, and Gly160. The following distance con- MWSV Met Trp Ser Val 2400
straints (3 A˚) were used for docking of BG into the active site of PRSG Pro Arg Ser Gly n.d.
hAGT: OH group of Tyr114 to N3 of BG; carbonyl of Cys145 to N2 FREG Phe Arg Glu Gly n.d.
of BG; carbonyl of Val148 to N2 of BG; NH of Ser159 to O6 of BG. W160hAGT Pro Asn Ser Trp 1000
Docking was done using the software MOLOC.
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were expressed and purified as glutathion S-transferase
(GST) fusion proteins [9]. For the determination of the
activity of the selected mutant proteins, the second-
order rate constants (kobs) of the reaction of the GST-
hAGT fusion proteins with 3a were measured (Table 1).
3a was used as a substrate in these measurements, as
its reaction with hAGT can be readily followed by West-
ern blotting, using a streptavidin-peroxidase conjugate
to detect and quantify biotinylation [9]. The second-
order rate constants were determined at concentrations
of 3a (5 M) where the measured rate depended lin-
early on the concentration of 3a.
Figure 3. Labeling of Nuclear Targeted hAGT in AGT-Deficient CHOAll of the characterized mutants possessed enhanced
Cellsactivities against 3a, with PGEGhAGT being a factor of 20
(A) Relative fluorescence intensity in the nucleus of AGT-deficientmore active than wild-type hAGT, demonstrating the
CHO cells expressing nuclear targeted PGEAhAGT or W160hAGT and
success of the selection scheme. The sequences of the labeled with varying concentrations of 4. Shown data are the average
active clones yield interesting insights into the interac- for more than ten cells.
tion of hAGT with BG; at position 140, seven out of nine (B) Confocal micrograph of nuclear targeted PGEAhAGT in AGT-defi-
cient CHO cells showing an overlay of transmission and fluores-clones possess a proline. The two other amino acids
cence channel (ex. 488 nm). The image was recorded 30 min afteridentified at this position, phenylalanine and methionine,
pulse labeling with 4 (500 nM) for 5 min and three washes with PBSwould also allow for the proposed hydrophobic interac-
buffer. Bar  10 m.
tion with the benzyl ring of BG [17–19]. At position 157,
glycine was found in five out of nine clones, whereas at
derivative 5 [2, 9]. W160hAGT possesses an about 2-foldposition 159, only polar side chains capable of hydrogen
higher activity than wild-type against BG derivatives (Ta-bonding were found, indicating that in the interaction
ble 1) and has been previously used in the in vivo fluores-of wild-type hAGT with BG, Ser159 and not Asp157
cence labeling of hAGT fusion proteins [9]. To ensureundergoes hydrogen bonding with the N7 of BG. The
localization of the two proteins in the nucleus of the cell,two most active clones, PGEGhAGT and PGEAhAGT, possess
they were fused to three consecutive simian virus 40a glutamic acid at position 159, and a favorable interac-
large antigen nuclear localization domains [21], yieldingtion between this residue and BG might result from hy-
W160hAGT-NLS3 and PGEAhAGT-NLS3, respectively. AGT-drogen bonding between deprotonated Glu159 and a
deficient CHO cells transiently expressing W160hAGT-tautomer of BG that has a hydrogen atom bound to the
NLS3 or PGEAhAGT-NLS3 were incubated for 5 min withN7 of BG. To test this hypothesis, we investigated the
varying concentrations of 4 and washed three times toactivity of wild-type hAGT and PGEAhAGT against the nu-
remove excess fluorophore, and the intensity of the fluo-cleoside 3b in which the N7 can only act as a hydrogen
rescence signal in the nucleus of the cell was measuredbond acceptor. Compared to their respective activities
using laser scanning confocal microscopy (Figure 3A).against 3a, the activity of wild-type hAGT against 3b
Cells transiently expressing PGEAhAGT-NLS3 displayed(340 s1M1) was not significantly affected, whereas the
a fluorescence signal in the nucleus that was signifi-activity of PGEGhAGT against 3b (1200 s1M1) decreased
cantly stronger than that of cells transiently expressingby a factor of 5. Thus, Glu159 might indeed act as a
W160hAGT-NLS3 (Figure 3A). In particular, fluorescencehydrogen bond acceptor in the interaction of PGEGhAGT
labeling of PGEAhAGT was still clearly detectable afterwith BG. Gly160 was either conserved or mutated to
incubations with 4 at concentrations as low as 500 nMhydrophobic residues, underlining previous observa-
(Figure 3B), whereas no significant labeling of W160hAGT-tions that polar amino acids at this position reduce the
NLS3 could be detected under these conditions. Thereaction rate of hAGT with BG [20].
data thus confirm the in vitro measurements and clearlyIt is instructive to compare the rate of the labeling of
demonstrate the superiority of the selected mutant pro-the selected hAGT mutants with the rates of complex
teins for the in vivo labeling of hAGT fusion proteins.formation between biarsenical ligands and tetracysteine
The in vivo labeling of fusion proteins for functionalmotifs [8], a reaction that has been successfully used
studies has the potential to become an attractive alter-for in vivo protein labeling. Second-order rate constants
native to more traditional approaches in which autofluo-for the reaction of biarsenical ligands complexed by
rescent proteins or epitope tags are fused to the proteinsimple dithiols with tetracysteine motifs of the type Cys-
of interest. In particular, in vivo labeling opens up theCys-Xxx-Xxx-Cys-Cys (where Xxx is any amino acid ex-
possibility to provide proteins with properties that can-cept cysteine) have been reported to be around 104
not be genetically encoded, and a single fusion proteins1M1 [8] and are thus comparable to those measured
can be labeled with a variety of different molecules forfor PGEGhAGT and PGEAhAGT.
completely different purposes [2–9]. Furthermore, sim-We then investigated if the selected mutants allow for
ple pulse-chase labeling experiments can discriminatea more efficient labeling of hAGT fusion proteins in vivo.
between old and new copies of a fusion protein in a livingToward this end, we compared the fluorescence labeling
cell, thereby allowing study of its life cycle, mobility, andof nuclear targeted PGEAhAGT and W160hAGT with 4 in
stability as well as that of the macromolecular assem-AGT-deficient CHO cells [11]. 4 contains the membrane-
blies it participates in [7]. Currently, there are two tagspermeable diacetate of fluorescein as label, which inside
the cell is hydrolyzed into the corresponding fluorescein that seem to be particularly well suited for the in vivo
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of methanol in dichloromethane (0%, 5%, 20% methanol). Solventlabeling of fusion proteins with small molecules: the
was evaporated in vacuo, and the product dissolved in 100l DMSO.tetracysteine motif which forms reversible complexes
The concentration of 2 (66 mM) was determined by measuring UVwith biarsenical compounds [6–8] and the here dis-
absorbance at   280 nm using the extinction coefficient of O6-
cussed hAGT which irreversibly reacts with BG deriva- (4-aminomethyl-benzyl)guanine (280  7.1 mM1cm1). Yield: 5.4 mg
tives [9]. In general, the scope of applications of such (0.0066 mmol, 87%). Rf  0.35 (20% methanol in dichloromethane).
MS(ESI) m/z (%)  814.37 (100 [M	H]	), 1628.32 (12 [2M	H]	).tags is affected by a possible interference of the tag
with the natural function of the protein to be studied,
Library Preparation and Phage Selectionsby the possibility to use them in different cell types and
For the library generation, saturation mutagenesis of residues 140,organelles as well as by the selectivity, efficiency, and
157, 159, and 160 was performed by overlap extension PCR usingspeed of the labeling reaction. Up to now, the main
the following four synthetic oligonucleotides in which the codons
restriction for the use of hAGT fusion proteins in mam- of the four residues 140, 157, 159, and 160 were randomized as
malian cells was the necessity to work in AGT-deficient NNK: primer 1: CTA CTC GCG GCC CAG CCG GCC ATG GCG GAC
TAC AAA GAC ATG GAC AAG GAT TGT GAA ATG; primer 2: GGAcell lines [9]. However, the here demonstrated possibility
ATT CGG CCC CCG AGG CCG C GTT TCG GCC AGC AGG CGG;to engineer the specificity and reactivity of hAGT
primer 3: C AGA GTG GTC TGC AGC AGC GGA GCC GTG GGCthrough directed evolution not only improves the effi-
NNK TAC NNK NNK GGA CTG GCC GTG AAG GA; and primer 4: Gciency and speed of the labeling of hAGT fusion proteins
CTC CGC TGC TGC AGA CCAC TCT GTG GCA CGG GAT GAG GAT
but also points toward one potential solution of this MNN GAC AGG ATT GCC TCT. The theoretical number of possible
problem. mutants on the DNA level is 106. Primers 1 and 2 contain SfiI restric-
tion sites (underlined), primers 3 and 4 contain the randomized
bases. The PCR product was ligated into phage display vectorSignificance
pAK100 and electroporated into E. coli XL1-Blue, yielding a library
of 4.4  105 independent clones. In about 60% of the clones, i.e.,The in vivo labeling of proteins with synthetic mole-
2.6  105, the tetracycline resistance cassette in pAK100 was re-
cules capable of probing and controlling protein func- placed by the hAGT insert. Colonies were scraped off the plates
tion has the potential to become an important method and grown in 2YT medium (25 mg/ml chloramphenicol, 1% glucose,
1 mM MgCl2) at 37
C until the optical density OD600 reached 0.6.in proteomics. We previously introduced a method for
VCS M13 helper phage were added to a final concentration of 4 the in vivo labeling of fusion proteins of the human
109 particles/ml, and the culture was incubated for 30 min at 37
CDNA repair protein O6-alkylguanine-DNA alkyltransfer-
without shaking and 3 hr at 37
C at 180 rpm. Cells were harvestedase (hAGT) that is based on the irreversible reaction
by centrifugation (2500  g, 5 min), resuspended in SB-MOPS (50
of hAGT with O6-benzylguanine derivatives. Using di- mM 3-morpholinopropanesulfonic acid, 25 mg/ml chloramphenicol,
rected evolution, we report here the generation and 70 mg/ml kanamycin, 1 mM MgCl2), and subsequently incubated
overnight at 24
C, 200 rpm. Cells were pelleted, and the supernatantcharacterization of hAGT mutants with significantly
containing the phage was adjusted to 1 mM DTT and stored at 4
Cincreased activity against substituted BG derivatives
prior to selections. Phage titers were typically around 1012–1013 cfu/and their use in the in vivo labeling of hAGT fusion
ml at this point (colony forming unit). For the selections, 2 was addedproteins. The increased in vitro activity of hAGT
to phage (1012 cfu/ml) to a final concentration of 1 M and gently
against BG derivatives directly translates into a much rotated for 10 min. In the second and third rounds of the selections,
more efficient in vivo protein labeling, making the se- the incubation time was reduced to 5 min and 40 s, respectively.
The reaction was quenched by addition of free BG to a final concen-lected mutants valuable tools for studying protein
tration of 100M. Phage were precipitated using polyethylene glycolfunction in the living cell. In particular, genetically en-
8000 (4% w/v) and NaCl (3% w/v), centrifuged, and resuspended incoded tags such as hAGT that allow for the selective
500 l PBS supplemented with 1 mM DTT. To this solution, 500 llabeling of fusion proteins with a variety of different
PBSMM (PBS supplemented with 4% skimmed milk powder) was
probes in vivo and in vitro should be attractive choices added and gently rotated for 60 min at 24
C. 75l of anti-digoxigenin
for genome-wide applications. In addition to these antibody-coated magnetic beads (Roche; washed three times with
PBS and blocked for 60 min with PBSMM) were added to the phagepractical applications, the results also provide insight
preparation and rotated at 4
C for 25 min. After immobilization ofinto the interaction of hAGT with its inhibitor BG.
labeled phage, the beads were washed three time with PBSMM,
once with PBST (PBS supplemented with 0.05% Tween-20), threeExperimental Procedures
times with 50 mM Tris (pH 7.4), 150 mM NaCl, 0.005% TX100, and
2 mM CaCl2, and twice with PBS. Phage were eluted by incubatingGeneral
the beads with 100 l 0.1 M glycine (pH 2.5) for 5 min, and theChemicals were purchased from Sigma or Roche. Flash column
solution was neutralized with 50l 1 M Tris-Cl (pH 8.0). E. coli JM101chromatography was performed on silica gel 60 (40–63 m, Fluka).
were infected with eluted phage, plated on 2YT plates (supple-Mass spectra were recorded by electrospray ionization on a Finni-
mented with 1% glucose, 25 mg/ml chloramphenicol), and incu-gan MAT APCI/ESI SSQ 710C spectrometer. UV spectra were mea-
bated overnight at 37
C. In general, between 105 and 106 phagesured on a Perkin Elmer Lambda10 UV/VIS spectrometer. Com-
were eluted after each round. The next day, colonies were scrapedpounds 3a, 3b, 4, and 5 were synthesized as described previously
off the plates, aliquoted, and stored at80
C prior to the next round[9, 13].
of selection. After the third round of selections, the percentage of
phage conferring tetracycline resistance to E. coli JM101 droppedO6-[4-(Digoxigenin-3-O-Methyl Carbonyl--Aminocaproic
from 40% to about 0.03%.Acid)-Amidomethyl)]-Benzylguanine 2
10.3 mg (0.038 mmol) of O6-(4-aminomethyl-benzyl)guanine was dis-
solved in 1 ml dry DMF (40
C, sonicated for 30 min) under argon Characterization of Selected hAGT Mutants as GST
Fusion Proteinsatmosphere. After cooling to room temperature, 2.5 l triethylamine
(0.018 mmol) and 5 mg (0.0076 mmol) digoxigenin-3-O-methyl car- The gene of the selected mutants was amplified by PCR and cloned
into the pGEX-2T expression vector (Pharmacia) as described forbonyl--aminocaproic acid N-hydroxysuccinimide ester in 0.5 ml
DMF were added. After stirring at room temperature for 3 hr, the wild-type [9]. Expression was done at 24
C, and the protein was
purified as a GST-hAGT fusion protein. For the measurements ofreaction was quenched with 100 l water, and the product was
purified by flash column chromatography using a stepwise gradient the reaction rates between the hAGT mutant proteins and 3a, protein
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(0.2–0.4 M) was incubated with 3a (1–5 M) in reaction buffer (50 in vivo: synthesis and biological applications. J. Am. Chem. Soc.
124, 6063–6076.mM HEPES [pH 7.2], 1 mM DTT) at 24
C, and aliquots were taken
at defined times. The aliquots were quenched with O6-benzylguanine 9. Keppler, A., Gendreizig, S., Gronemeyer, T., Pick, H., Vogel, H.,
and Johnsson, K. (2003). A general method for the covalent(1 mM final concentration) and analyzed by Western blotting using a
Neutravidin peroxidase conjugate (Pierce) and a chemiluminescent labeling of fusion proteins with small molecules in vivo. Nat.
Biotechnol. 21, 86–89.peroxidase substrate (Renaissance Reagent Plus, NEN). The intensi-
ties of the bands on the Western blot were analyzed using an image 10. Pegg, A.E. (2000). Repair of O(6)-alkylguanine by alkyltransfer-
ases. Mutat. Res. 462, 83–100.station (Kodak 440), and the data fitted to a pseudo first-order reac-
tion model. Second-order rate constants were obtained by dividing 11. Kaina, B., Fritz, G., Mitra, S., and Coquerelle, T. (1991). Transfec-
tion and expression of human O6-methylguanine-DNA methyl-the pseudo first-order rate constants by the concentration of 3a.
transferase (MGMT) cDNA in Chinese hamster cells: the role of
MGMT in protection against the genotoxic effects of alkylatingFluorescence Labeling of hAGT in AGT-Deficient CHO Cells
agents. Carcinogenesis 12, 1857–1867.Fusion proteins W160hAGT-NLS3 and PGEAhAGT-NLS3 were con-
12. Smith, G.P. (1985). Filamentous fusion phage: novel expressionstructed by ligation of the two corresponding hAGT genes into the
vectors that display cloned antigens on the virion surface. Sci-mammalian expression vector pECFP-Nuc (Clontech) using the re-
ence 228, 1315–1317.striction sites NheI and BglII. Chinese hamster ovary (CHO) cells
13. Damoiseaux, R., Keppler, A., and Johnsson, K. (2001). Synthesisdeficient in O6-alkylguanine-DNA alkyltransferase (AGT) were trans-
and applications of chemical probes for human O6-alkylgua-fected with the resulting plasmids as described [9, 22]. After tran-
nine-DNA alkyltransferase. ChemBioChem 2, 285–287.sient expression of the fusion proteins for 24 hr, cells were pulse
14. Krebber, A., Bornhauser, S., Burmester, J., Honegger, A., Wil-labeled with 4 at varying concentrations for 5 min in a microscope
luda, J., Bosshard, H.R., and Pluckthun, A. (1997). Reliable clon-chamber. Excess substrate was removed by three washes with PBS,
ing of functional antibody variable domains from hybridomasand the cells were incubated for 30 min with PBS. Laser scanning
and spleen cell repertoires employing a reengineered phageconfocal micrographs were recorded using a 488 nm argon/krypton
display system. J. Immunol. Methods 201, 35–55.laser line on a Zeiss LSM 510 microscope (Carl Zeiss AG) with a
15. Janda, K.D., Lo, C.H., Li, T., Barbas, C.F., 3rd, Wirsching, P.,63 water (1.2 numerical aperture) objective. Scanning speed and
and Lerner, R.A. (1994). Direct selection for a catalytic mecha-laser intensity were adjusted to avoid photobleaching of the fluores-
nism from combinatorial antibody libraries. Proc. Natl. Acad.cent probes and damage or morphological changes of the cells. For
Sci. USA 91, 2532–2536.the determination of the relative intensity of the fluorescence signal
16. Damoiseaux, R., Schultz, P.G., and Johnsson, K. (2002). To-in the nucleus of the cell as a function of the concentration of 4,
wards the generation of artificial O6-alkylguanine-DNA alkyl-more than 10 cells were analyzed at each concentration of 4, and
transferases: in vitro selection of antibodies with reactive cys-the mean value was calculated.
teine residues. Chembiochem 3, 573–575.
17. Wibley, J.E., Pegg, A.E., and Moody, P.C. (2000). Crystal struc-
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